[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Funding Opportunity: Weston Brain Institute



The Office of Research Services has received the following information which we are forwarding to our e-mail list members:

cid:image001.jpg@01D07D1A.DDCC4D80

Canada: Rapid Response 2017

PD-Related Diseases

 

Hello, 

 

I am writing on behalf of the Weston Brain Institute, which supports translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging.  We are pleased to launch the Canada: Rapid Response 2017 program for PD-related diseases.

 

Please share this message with your colleagues and researchers.

 

Program Overview

 

Seed funding for novel, high-risk, high-reward translational research ideas to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging.

Funding 

Up to $200,000 over up to 18 months

Eligibility

Principal applicants must be at or above the level of postdoctoral researcher at a CRA qualified institution located in Canada.

Project must involve the development of a therapeutic, and/or a tool to help accelerate the development of therapeutics for neurodegenerative diseases of aging

Disease Groups

This program is run through alternating calls that are disease focused.

PD-related diseases:

PD, PSP, LBD, MS,  prodromes, and vascular contributions to the listed diseases

 

Currently open

AD-related diseases:

AD, FTD, MCI and prodromes, and vascular contributions to the listed diseases  

 

Launch: May 2017

 

Current Call

Important Dates

PD-related diseases

Program Information Session:

April 4th, 2017 at 1pm EDT (Register here)

Letter of Intent Deadline:

May 9th, 2017 at 2pm EDT

Anticipated Award:

October 2017

 

APPLY HERE

 

NEW for 2017

1.       Multiple calls per year, alternating between 2 different disease groups: AD-related & PD-related.

2.       Projects may now request up to $200,000 per project (previous years, $150,000) over up to 18 months.

3.       Applicants may appear in any role on any number of Letters of Intent (LOI).

 

For more information, please see the attached Request for Applications (RFA) or visit our website. Contact me with any questions, including whether a potential idea is in scope.

 

Thank you,

Cristina

 

Cristina Tang, PhD | Senior Specialist, Research Programs, Weston Brain Institute | 22 St. Clair Ave. E, Toronto, Canada, M4T 2S3 | +1-416-965-5356 | cristina.tang@weston.ca | www.westonbraininstitute.ca

 

 

This email message is confidential, may be legally privileged and is intended for the exclusive use of the addressee. If you received this message in error or are not the intended recipient, you should destroy the email message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained. Please inform us of the delivery error by return email. Thank you for your cooperation.

Le présent message électronique est confidentiel et peut être couvert par le secret professionnel. Il est à l’usage exclusif du destinataire. Si vous recevez ce message par erreur ou si vous n’en êtes pas le destinataire prévu, vous devez détruire le message et toute pièce jointe ou copie et vous êtes tenu de ne pas conserver, distribuer, divulguer ni utiliser tout renseignement qu’il contient. Veuillez nous informer de toute erreur d’envoi en répondant à ce message. Merci de votre collaboration.



Attachment: RR17 (PD) RFA.pdf
Description: RR17 (PD) RFA.pdf